PGNYProgyny, Inc.

$27.94+29% 1Y

Is it growing?

Good

Growing: earnings up +56% year on year and operating margin widening (+2.4 points).

2 good, 1 neutral
Revenue trend+6% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +24% a year.

Earnings trend+56% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+2.4 points operating

Trailing-twelve-month operating margin, 8.5% now against 6.1% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbetter than 70% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is PGNY growing?

Progyny, Inc. has grown revenue 11% a year over three years and 24% a year over five, with earnings per share compounding at −82%.

+11%

Revenue growth, 3-year annual rate · Healthcare Plans median +7.8% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate
+24%

Revenue growth, 5-year rate · +11% over three · growth has slowed since the five-year average

Earnings per share, 3-year rate
−82%

Earnings per share, 3-year rate · revenue +11% · earnings lagged revenue: the growth is costing something

Years of annual history on file
9

Years of annual history on file · FY2017 to FY2025, as filed

Details›
Revenue FY2021
$501M
Revenue FY2022
$787M
Revenue FY2023
$1.09B
Revenue FY2024
$1.17B
Revenue FY2025
$1.29B

Annual income statements as filed with the SEC.